Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lyra Therapeutics

7.90
-0.6500-7.60%
Post-market: 7.900.00000.00%19:42 EDT
Volume:59.74K
Turnover:482.62K
Market Cap:12.63M
PE:-0.13
High:8.52
Open:8.48
Low:7.85
Close:8.55
Loading ...
May 31, 2022

Major Issues Report

8-K - Current report
May 18, 2022

Correspondence

CORRESP [Cover] - Correspondence
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2022

Major Issues Report

8-K - Current report
Apr 22, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 14, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 13, 2022

Major Issues Report

8-K - Current report
Mar 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2022

Major Issues Report

8-K - Current report
Feb 18, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 15, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 11, 2021

Major Issues Report

8-K - Current report